Economy
Amgen, Astra Drug Duo Boosts Survival for Deadly Lung Cancer
Doctors combined powerful medicines from Amgen Inc. and AstraZeneca Plc and found they allowed patients with an aggressive form of lung cancer to live eight months longer.
Publication and source
PublicationSanalda Haber
SourceBloomberg
Published
CategoryEconomy
Summary from the source publisher’s news feed.